E-LIB Suche - Ergebnisse für: Bömer, Ulf

1

Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and..:

Bothe, Ulrich ; Günther, Judith ; Nubbemeyer, Reinhard...
Journal of Medicinal Chemistry. 67 (2024) 2 - p. 1225-1242 , 2024

Link: https://doi.org/10.1021/..

2

Discovery and Characterization of BAY-805, a Potent and Sel..:

Göricke, Fabian ; Vu, Victoria ; Smith, Leanna...
Journal of Medicinal Chemistry. 66 (2023) 5 - p. 3431-3447 , 2023

Link: https://doi.org/10.1021/..

3

A Novel NAMPT Inhibitor-Based Antibody–Drug Conjugate Paylo..:

Böhnke, Niels ; Berger, Markus ; Griebenow, Nils...
Bioconjugate Chemistry. 33 (2022) 6 - p. 1210-1221 , 2022

Link: https://doi.org/10.1021/..

4

The potent AMPK inhibitor BAY-3827 shows strong efficacy in..:

Lemos, Clara ; Schulze, Volker K. ; Baumgart, Simon J....
Cellular Oncology. 44 (2021) 3 - p. 581-594 , 2021

Link: https://doi.org/10.1007/..

5

BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor whi..:

Berger, Markus ; Wortmann, Lars ; Buchgraber, Philipp...
Journal of Medicinal Chemistry. 64 (2021) 17 - p. 12723-12737 , 2021

Link: https://doi.org/10.1021/..

6

Changing for the Better: Discovery of the Highly Potent and..:

Lücking, Ulrich ; Kosemund, Dirk ; Böhnke, Niels...
Journal of Medicinal Chemistry. 64 (2021) 15 - p. 11651-11674 , 2021

Link: https://doi.org/10.1021/..

7

Damage Incorporated: Discovery of the Potent, Highly Select..:

Lücking, Ulrich ; Wortmann, Lars ; Wengner, Antje M....
Journal of Medicinal Chemistry. 63 (2020) 13 - p. 7293-7325 , 2020

Link: https://doi.org/10.1021/..

8

Treating Cancer by Spindle Assembly Checkpoint Abrogation: ..:

Schulze, Volker K. ; Klar, Ulrich ; Kosemund, Dirk...
Journal of Medicinal Chemistry. 63 (2020) 15 - p. 8025-8042 , 2020

Link: https://doi.org/10.1021/..

9

Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibito:

Lefranc, Julien ; Schulze, Volker Klaus ; Hillig, Roman Christian...
Journal of Medicinal Chemistry. 63 (2019) 2 - p. 601-612 , 2019

Link: https://doi.org/10.1021/..

10

Discovery of Rogaratinib (BAY 1163877): a pan‐FGFR Inhibito:

Collin, Marie‐Pierre ; Lobell, Mario ; Hübsch, Walter...
ChemMedChem. 13 (2018) 5 - p. 437-445 , 2018

Link: https://doi.org/10.1002/..

11

BAY 1143269, a novel MNK1 inhibitor, targets oncogenic prot..:

Santag, Susann ; Siegel, Franziska ; Wengner, Antje M....
Cancer Letters. 390 (2017) - p. 21-29 , 2017

Link: https://doi.org/10.1016/..

12

Identification of Atuveciclib (BAY 1143572), the First High..:

Lücking, Ulrich ; Scholz, Arne ; Lienau, Philip...
ChemMedChem. 12 (2017) 21 - p. 1776-1793 , 2017

Link: https://doi.org/10.1002/..

13

BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhib..:

Politz, Oliver ; Siegel, Franziska ; Bärfacker, Lars...
International Journal of Cancer. 140 (2016) 2 - p. 449-459 , 2016

Link: https://doi.org/10.1002/..

14

A Cost-Effective Solution to Reduce Dead Volume of a Standa..:

Bergsdorf, Christian ; Gewiese, Nadine ; Stolz, Andreas...
SLAS Discovery. 11 (2006) 4 - p. 407-412 , 2006

Link: https://doi.org/10.1177/..

15

High‐Throughput Screening for Kinase Inhibitors:

von Ahsen, Oliver ; Bömer, Ulf
ChemBioChem. 6 (2005) 3 - p. 481-490 , 2005

Link: https://doi.org/10.1002/..